New regimens as first-line eradication therapy for Helicobacter pylori infection in patients allergic to penicillin: A randomized controlled trial.
Yuxin ZhangBaojun SuoXueli TianHua ZhangHaoping LuXingyu YaoCailing LiXinlu RenLi-Ya ZhouZhi-Qiang SongPublished in: Helicobacter (2023)
The efficacies of three bismuth quadruple therapies containing minocycline, cefuroxime, and full-dose metronidazole (pairwise) for first-line H. pylori eradication in penicillin-allergic patients were similarly satisfactory with relatively good safety and compliance. The study was registered in the Chinese Clinical Trials Registration (ChiCTR1900023702).